By 2030, an estimated 15 million people are expected to be using GLP-1 drugs for weight loss. We wanted to know: What opportunities does this present for food retailers and brands? If people on weight-loss programs buy less food, how do they compensate for nutrition? We’re asking users of weight-loss programs how changes in diet ...
Read more